'This publication by @BurgosLeire supports broader #MRD use in myeloma. #mmsm https://t.co/d2BJ3799pK clonoSEQ is FDA-cleared to assess MRD in patients with MM and B-ALL. For important info. incl. sample types & test limitations: https://t.co/sE39cuZx
RT @bdermanmd: For a well-written and concise review of where we are at with MRD to potentially guide decision making in myeloma, see below…
For a well-written and concise review of where we are at with MRD to potentially guide decision making in myeloma, see below. #mmMRD https://t.co/YBQqHPpfvM